|
|
|
|
 |
|||
|
|||
Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues
PG Chesa, WJ Rettig, TM Thomson, LJ Old and MR Melamed
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Nerve growth factor (NGF) is a polypeptide important for normal development of the nervous system and promotion of survival and differentiation of sensory and sympathetic neurons in culture. The cellular effects of NGF are mediated by a specific cell surface molecule, nerve growth factor receptor (NGF-R). In the present study we have used a monoclonal antibody against human NGF-R to examine, by the avidin-biotin-immunoperoxidase method, the receptor distribution in a wide range of normal tissues and in more than 200 malignant tumors. Our results show that (a) human NGF-R is expressed in the peripheral nervous system but not in any of the central nervous system areas tested; (b) NGF-R expression is not restricted to neural tissues but is also found in a number of normal epithelial, mesenchymal, and lymphoid tissues; (c) NGF-R expression changes during normal development; and (d) NGF-R expression in malignant tumors generally parallels its normal tissue distribution. Thus, NGF-R is detected in a proportion of neuroectoderm-derived tumors, carcinomas, and lymphomas, and also in a characteristic group of small round-cell tumors (Ewing's sarcomas and embryonal rhabdomyosarcomas). These findings suggest a normal regulatory role for NGF in both neuronal and non-neuronal cells and identify a range of human tumors in which the NGF/NGF-R system may contribute to the malignant phenotype.
Volume 36,
Issue 4,
pp. 383-389,
04/01/1988
Copyright © 1988 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Davidson, P. Lazarovici, A. Ezersky, J. M. Nesland, A. Berner, B. Risberg, C. G. Trope, G. B. Kristensen, M. Goscinski, G. van de Putte, et al. Expression Levels of the Nerve Growth Factor Receptors TrkA and p75 in Effusions and Solid Tumors of Serous Ovarian Carcinoma Patients Clin. Cancer Res., November 1, 2001; 7(11): 3457 - 3464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ricci, S. Greco, S. Mariotta, L. Felici, E. Bronzetti, A. Cavazzana, G. Cardillo, F. Amenta, A. Bisetti, and G. Barbolini Neurotrophins and Neurotrophin Receptors in Human Lung Cancer Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 439 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pica, A. Volpi, A. Serafino, M. Fraschetti, O. Franzese, and E. Garaci Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells Blood, May 1, 2000; 95(9): 2905 - 2912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Sariola, M Saarma, K Sainio, U Arumae, J Palgi, A Vaahtokari, I Thesleff, and A Karavanov Dependence of kidney morphogenesis on the expression of nerve growth factor receptor Science, October 25, 1991; 254(5031): 571 - 573. [Abstract] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |